A report from TheBusinessResearchCompany shows that the "Global Cough And Cold Preparations Market 2019" is expected to grow to $26.61 billion at a CAGR of 3.5% through 2022. Read more at https://bit.ly/2lFEPaS
Manufacturers operating in the global cold, cough and sore throat remedies market are likely to target emerging economies through mergers with established local players to increase their customer base. While considering the overall market approach the analysts of Future Market Insights have observed that key players are focussing on the need to efficiently meet requirements of various dosage types, by ensuring best combination products to effectively treat cold, cough and sore throat, and Rx to OTC switch so that products can be easily available to customers. In a new report titled “Cold, Cough and Sore Throat Remedies Market: Global Industry Analysis and Opportunity Assessment 2016–2026,” we have observed that strengthening of supply chain particularly in regions such as Asia Pacific excluding Japan and the Middle East and Africa are key focus areas for players in this market.
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027.
TBRC global cough and cold preparations market report includes antihistamines, expectorants, bronchodilators, decongestants, antibiotics. https://bit.ly/31zHwA7
A recent report published by TheBusinessResearchCompany on Cough And Cold Preparations Market provides in-depth analysis of segments and sub-segments in the global as well as regional. http://bit.ly/36Vklgr
The global cough and cold preparations market size is expected to grow from $61.84 billion in 2021 to $66.61 billion in 2022 at a compound annual growth rate (CAGR) of 7.7%.
The global cough and cold preparations market is expected to decline from $14.94 billion in 2020 to $13.02 billion in 2021 at a compound annual growth rate (CAGR) of -12.9%.
TBRC global cough and cold preparations market report includes bronchodialators, anticholinergic, pulmonary antihypertensives, antihistamines, expectorants
Cold, Cough and Sore Throat Remedies Market: Oral Syrups Segment Will Remain the Most Attractive and Dominant Dosage Type Segment Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016 - 2026
A newly published report by Market Statsville Group (MSG), title Global OTC Drugs Market provides an exhaustive analysis of significant industry insights and historical and projected global market figures. MSG expects the global OTC Drugs market will showcase an impressive CAGR from 2024 to 2033. The comprehensive OTC
The global OTC drugs market is estimated to garner a revenue of ~ USD 294 billion by the end of 2035 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2035.
According to the latest research report by IMARC Group, The global over the counter (OTC) drugs market size reached US$ 168.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 275.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032. More Info:- https://www.imarcgroup.com/over-the-counter-drugs-market
According to the latest research report by IMARC Group, The global over the counter (OTC) drugs market size reached US$ 158.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 231.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.24% during 2023-2028. More info:- https://www.imarcgroup.com/over-the-counter-drugs-market
According to the latest research report by IMARC Group, The United States over the counter (OTC) drugs market size reached US$ 25.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 37.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.45% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-over-the-counter-drugs-market
According to the latest research report by IMARC Group, The India over the counter (OTC) drugs market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.4 Billion by 2028, exhibiting a growth rate (CAGR) of 16.7% during 2023-2028. More Info:- https://www.imarcgroup.com/india-over-the-counter-drugs-market
A recent report published by The Business Research Company on Respiratory Diseases Drugs Market provides in-depth analysis of segments and sub-segments in the global as well as regional. https://bit.ly/2DNmVwu
According to the latest research report by IMARC Group, The global over the counter (OTC) drugs market size reached US$ 158.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 231.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.24% during 2023-2028. More Info:- https://www.imarcgroup.com/over-the-counter-drugs-market
The Business Research Company’s Respiratory Diseases Drugs Global Market Report 2019 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. http://bit.ly/31bXlaB
The global respiratory diseases drugs market size is expected to reach $70 billion by 2022, significantly growing at a CAGR of around 6.5% during the forecast period.
Marketreportsonchina.com presents a report on “Report on Respiratory Drugs Markets in China”. http://www.marketreportsonchina.com/life-sciences-market-research-reports-12316/respiratory-drugs-china.html China's demand for Respiratory Drugs has grown at a fast pace in the past decade.
According to the latest research report by IMARC Group, The India over the counter (OTC) drugs market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.4 Billion by 2028, exhibiting a growth rate (CAGR) of 16.7% during 2023-2028. More Info:- https://www.imarcgroup.com/india-over-the-counter-drugs-market
The major players in the global respiratory diseases drugs market are GlaxosmithKline Plc, AstraZeneca Plc, Merck & Co, Novartis AG, Johnson & Johnson. Read More @ https://bit.ly/37Kt2MO
The major players covered in the global respiratory diseases drugs market are GlaxosmithKline Plc, AstraZeneca Plc, Merck & Co, Novartis AG, Johnson & Johnson..... @ @ https://bit.ly/37Kt2MO
Bharat Book Presents"Cough, Cold and Allergy (Hay Fever) Remedies in China" offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
North America was the largest region in the respiratory diseases drugs market in 2017, accounting for 48% market share. Read Report https://www.thebusinessresearchcompany.com/report/respiratory-diseases-drugs-global-market-report-2018
Respiratory Diseases Drugs Market Global Report 2020 is the latest research report added to The Business Research Company database. The report is covered in 150 pages covering 5 major players in the industry.
The Global Over-the-counter (OTC) drugs market share report provides numbers for applications and regional segments of the industry covering historical as well as forecast data for decision makers.
In the report, the market has been segmented on the basis of technology, product type, application, and end-users. On the basis of technology, the molecular diagnostics market is expected to grow at the highest CAGR from 2012 to 2017.
Their revised schedule provided for shorter age ranges for a given dose: 2-3, 4 ... Adults and Children 12 years of age and older: 'Approved Adult Dose' ...
The report on Empty Capsules Market by product (non-gelatin capsules, gelatin capsules), application (vitamins & dietary supplements, cardiac therapy drugs, anti-inflammatory & anti-rheumatic drugs, cold preparations), end user(nutraceutical industry, cosmeceutical industry, research laboratories) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Empty Capsules Market is projected to grow at a CAGR of 7.8% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
Global otc drug and dietary supplement market size is expected to reach $438.93 Bn by 2028 at a rate of 7.2%, segmented as by category, vitamin and dietary supplements, cough and cold products, analgesics, gastrointestinal products, sleep aids
Another factor that is propelling the market among customers is hygiene. Increase in the number of diseases, such as allergies, colds, and coughs, are critical concerns for companies, which has led to the introduction of anti-viral facial tissue papers. The presence of a large number of participants in the fragmented market landscape is posing challenges for the manufacturers of facial tissue paper.
"Global empty capsule market was valued at USD 1,970 million in 2017 and is expected to grow at a CAGR of 7.4% during the forecast period, 2019–2026. "
The Over-the-Counter (OTC) drug market, valued at an impressive $162.2 billion in 2022, steps in. Projected to reach a staggering $245.9 billion by 2032, with a healthy CAGR of 5.3%.
"According to HTF Market Intelligence, the Paracetamol market is expected to see a growth rate of 3.3% and may see market size of USD1,278 Million by 2029."
"According to HTF Market Intelligence, the Paracetamol market is expected to see a growth rate of 3.3% and may see market size of USD1,278 Million by 2029."
The Business Research Company’s “Respiratory Diseases Drugs Global Market Report 2019” under its pharmaceutical drugs category covers market characteristics, key players, market size and trends from 2019 to 2022.
More Information @ https://bit.ly/2ZzJ3Qi Erdosteine market demand from nasopharyngitis application may witness significant gains at around 5.5% by 2025. Increasing nasopharyngitis or common cold cases due to the rising allergy and weak immune system will boost the market for erdosteine based syrups and tablets. It is widely used in the pharmaceutical sector to reduce inflammation in the nasal passage.
Acetic anhydride is a primary raw material required for the production of pharma drugs and medicines. A global increase in general health issues following the onslaught of the COVID-19 pandemic has increased the demand for these medications. Rise in usage of generic drugs like paracetamol has caused a significantly positive impact across the global acetic anhydride market. Similarly, hormonal drugs are being increasingly used to treat chronic illnesses. A growing number of people contracting cancer, and developing conditions like hyperthyroidism, prostate disorders, and infertility is giving an impetus to market growth. For More Information of Acetic Anhydride Market Visit: https://www.fairfieldmarketresearch.com/report/acetic-anhydride-market
Instructor: Grace Earl, Pharm.D., Assistant Professor, ... Skunk. Boom. 45. MARIJUANA DOSAGE FORMS. Smoked as a cigarette or joint, or in a pipe or bong. ...
According to the Market Statsville Group (MSG), the Global Softgel Capsules Market size is expected to grow from USD 8,921.6 million in 2023 to USD 14,377.4 million by 2033, at a CAGR of 6.6% from 2023 to 2033.
The Over-the-counter drug market is flourishing. According to a report by Ken Research, the global OTC Drug market size reached a substantial $137.39 billion in 2024 and is projected to reach a staggering $163.10 billion by 2029, boasting a healthy CAGR (Compound Annual Growth Rate) of 3.49%.
Drugs and the Nervous System 1. Why study drugs? combat drug abuse combat anxiety, sleeplessness, depression, schizophrenia Good Drugs versus Bad Drugs ?
Analyze Future: Respiratory Drugs Markets in China To Get More Details @ http://www.analyzefuture.com/respiratory-drugs-in-china-market China's demand for Respiratory Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented.
Storage of fat in liver leads to fibrosis (scarring of liver tissue) ... Red spots or soreness of lips, gums that does not heal within two weeks. Repeated bleeding ...
The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.